23andMe Wins Approval of $305 Million Genetic Data Asset Sale

23andMe Holding Co. secured bankruptcy court approval to sell its genetic data trove to its co-founder and a related nonprofit for $305 million, despite staunch pushback from a slew of states that raised privacy concerns.

Judge Brian C. Walsh of the US Bankruptcy Court for the Eastern District of Missouri issued his written decision late June 27.

The sale to 23andMe co-founder Anne Wojcicki and TTAM Research Institute, which outbid Regeneron Pharmaceuticals for the assets, includes the genetic data of more than 13 million customers.

The judge acknowledged that the transaction raised “challenging issues involving sensitive information” and that ...